Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Smith and Nephew plc
Smith and Nephew plc
Activities:
Personal Protection
Manufacturing
Ingredients
Medical Devices
X
LinkedIn
Trending Articles
Merck's sacituzumab tirumotecan granted Breakthrough Therapy Designation by the FDA
The antibody-drug conjugate (ADC) can be used to treat patients with advanced or metastatic non-small cell lung cancer (NSCLC)
Novavax sells protein manufacturing facility to Novo Nordisk for $200m
Novo Nordisk's purchase of Novavax's Czech recombinant protein manufacturing facility will involve a full transfer of assets — including its workforce and associated support...
Precision psychiatry in action: How IMed Consultancy helped HMNC Brain Health’s Cortibon programme
AI-driven approach promises a new class of depression treatment
IMed Consultancy helps Toby Orthopaedics navigate UK regulations
Regulatory consultancy ensures compliance and confidence for Miami-based company
ACG launches ADAPT X at CPhI & PMEC India 2024
Innovative tablet feeder sets new benchmarks for efficiency and versatility in pharmaceutical packaging solutions
Upcoming event
CPhI Middle East
10–12 December 2024 | Conference | Riyadh, Saudi Arabia
See all
Related Content
Manufacturing
Smith & Nephew grows surgical robotics offering
The British medical technology company has invested in its digital surgery portfolio through the acquisition of Brainlab’s Orthopaedic Joint Reconstruction business and the opening of a new R&D centre
Finance
Smith & Nephew acquires Osiris to focus on regenerative medicine
The companies expect to close the transaction in the second quarter of 2019, subject to customary closing conditions
Recruitment
Smith and Nephew appoints Namal Nawana CEO
Finance
Graham Baker appointed Chief Financial Officer
Smith & Nephew plc (LSE:SN, NYSE:SNN), the global medical technology business, today announces the appointment of Graham Baker as Chief Financial Officer.
Subscribe now